Israel Hayom is a media organization founded on the belief that the Israeli public deserves better journalism—more balanced, more accurate, and more reliable. Journalism that speaks rather than shouts. Journalism that is trustworthy, objective, and matter-of-fact. A different kind of journalism, offered free of charge. The first print edition was published on July 30, 2007, and in 2010 Israel Hayom became the Israeli newspaper with the highest weekday readership. The newspaper’s publisher is Dr. Miriam Adelson. Its Editor-in-Chief is Omar Lachmanovitch, and its founding editor is Amos Regev. Israel Hayom’s Hebrew and English websites, as well as its Android and iOS applications, provide around-the-clock news coverage, exclusive content, breaking news and updates, analysis and commentary, video, podcasts, and live broadcasts. The digital platforms of Israel Hayom include news and opinion channels covering culture and entertainment, lifestyle, technology, sports, business and consumer affairs, health, military affairs, food, Judaism, tourism, and automobiles. In 2021, a new Hebrew-language website and mobile application were launched to provide users with a fast, up-to-date, secure, and convenient experience. The content of the newspaper’s print edition is also available online through a daily digital edition and can be received via newsletter. “The Israel Hayom Clique,” the publication’s exclusive benefits club, offers website users discounts and special promotions on products and services. Israel Hayom welcomes feedback, criticism, and suggestions for improvement from its readers. You can contact the organization by email at hayom@israelhayom.co.il

Tuesday Oct 27, 2026
NEWSLETTER
www.israelhayom.com
  • Home
  • News
    • Israel
    • Israel at War
    • Middle East
    • United States
  • Opinions
  • Jewish World
    • Archaeology
    • Antisemitism
  • Lifestyle
    • Food
    • Travel
    • Fashion
    • Culture
  • Magazine
    • Feature
    • Analysis
    • Explainer
  • In Memoriam
www.israelhayom.com
  • Home
  • News
    • Israel
    • Israel at War
    • Middle East
    • United States
  • Opinions
  • Jewish World
    • Archaeology
    • Antisemitism
  • Lifestyle
    • Food
    • Travel
    • Fashion
    • Culture
  • Magazine
    • Feature
    • Analysis
    • Explainer
  • In Memoriam
www.israelhayom.com
Home Health & Wellness

Israeli medical device maker raises $26M to fund cancer treatment trials

Alpha Tau says it has successfully completed its first-in-human clinical trial of Alpha DaRT, a radiation cancer therapy, with squamous cell carcinoma patients from Italy and Israel.

by  Reuters and ILH Staff
Published on  06-05-2020 17:00
Last modified: 06-05-2020 10:50
Israeli medical device maker raises $26M to fund cancer treatment trialsGetty Images/iStockphoto

Cancer cell | Photo: Getty Images/iStockphoto

Share on FacebookShare on Twitter

Israeli medical device maker Alpha Tau Medical said on Thursday it raised $26 million in a funding round from investors including Shavit Capital, Medison Ventures and OurCrowd to help finance global clinical trials.

Follow Israel Hayom on Facebook and Twitter

Alpha Tau said it has successfully completed its first-in-human clinical trial of Alpha DaRT – a radiation cancer therapy – with squamous cell carcinoma patients from Italy and Israel.

It is now conducting trials in other sites, such as its first US trial at Memorial Sloan Kettering Cancer Center in New York, a pancreatic cancer trial at CHUM in Montreal and trials at three academic institutions in Japan.

The company, it said, is also establishing new manufacturing facilities in Israel and elsewhere.

Subscribe to Israel Hayom's daily newsletter and never miss our top stories!

Tags: cancerIsrael

Related Posts

Nobel Prize in medicine goes to 3 for unlocking light-activated brain cellsJonathan Nackstrand / AFP

Nobel Prize in medicine goes to 3 for unlocking light-activated brain cells

by Erez Linn

The groundbreaking research allows scientists to manipulate individual nerve cells using light, opening new avenues in neuroscience.

Israeli company on verge of breakthrough in celiac drug developmentGetty Images/iStockphoto

Israeli company on verge of breakthrough in celiac drug development

by Nitzan Cohen

TEV '408 succeeded in blocking intestinal damage from gluten exposure, positioning Teva for a potentially lucrative entry into a market...

Nearly half of young Israeli men would preserve sperm, study findsIDF Spokesperson's Unit

Nearly half of young Israeli men would preserve sperm, study finds

by Maytal Yasur Beit-Or

Prof. Bella Savitsky, who lost her son on October 7, is now pushing for a state funded sperm bank for...

Menu

Analysis 

Archaeology

Blogpost

Business & Finance

Culture

Exclusive

Explainer

Environment

 

Features

Health

In Brief

Jewish World

Judea and Samaria

Lifestyle

Cyber & Internet

Sports

 

Diplomacy 

Iran & The Gulf

Gaza Strip

Politics

Shopping

Terms of use

Privacy Policy

Submissions

Contact Us

About Us

The first issue of Israel Hayom appeared on July 30, 2007. Israel Hayom was founded on the belief that the Israeli public deserves better, more balanced and more accurate journalism. Journalism that speaks, not shouts. Journalism of a different kind. And free of charge.

All rights reserved to Israel Hayom

Hosted by sPD.co.il

  • Home
  • News
    • Israel at War
    • Israel
    • United States
    • Middle East
    • Sports
  • Opinions
  • Jewish World
    • Archaeology
    • Antisemitism
  • Lifestyle
    • Food
    • Travel
    • Fashion
    • Culture
  • Magazine
    • Feature
    • Analysis
    • Explainer
    • Environment & Wildlife
    • Health & Wellness
  • In Memoriam
  • Subscribe to Newsletter
  • Submit your opinion
  • Terms and conditions

All rights reserved to Israel Hayom

Hosted by sPD.co.il

Newsletter

[contact-form-7 id=”508379″ html_id=”isrh_form_Newsletter_en” title=”newsletter_subscribe”]

  • Home
  • News
    • Israel at War
    • Israel
    • United States
    • Middle East
    • Sports
  • Opinions
  • Jewish World
    • Archaeology
    • Antisemitism
  • Lifestyle
    • Food
    • Travel
    • Fashion
    • Culture
  • Magazine
    • Feature
    • Analysis
    • Explainer
    • Environment & Wildlife
    • Health & Wellness
  • In Memoriam
  • Subscribe to Newsletter
  • Submit your opinion
  • Terms and conditions

All rights reserved to Israel Hayom

Hosted by sPD.co.il